Episode Details

Shadd Dales sits down with Ryan Crandall, Chief Commercial Officer at MariMed Inc. (OTCQX: MRMD), for a timely conversation on how the company is scaling smart, staying lean, and leading with brand-first execution in some of the most competitive cannabis markets in the U.S.Crandall shares what his expanded role now includes—from R&D to marketing—and how aligning these departments has helped sharpen the company’s product rollout strategy. The two discuss how Betty’s Eddies, Bubbies Baked, and the new Microdose mushroom-infused line are outperforming in key states like Massachusetts, Maryland, and Illinois.They also break down: • Why MariMed is sticking to a wholesale-first model • What the August 1 launch of adult-use cannabis in Delaware could mean for growth • How product consistency and disciplined SOPs set them apart • What’s working in fast-acting edibles and low-dose functional SKUs • Where the next real M&A opportunities might come from as reform slowly takes shapeWith federal attention potentially shifting to cannabis post–“Big Beautiful Bill,” Crandall also explains how MariMed is preparing for what could come next in banking and market expansion.#CannabisReform #MariMed #SAFERBanking #BettysEddies #CannabisStocks #CannabisBanking #CannabisStrategy #CannabisIndustry #CannabisInnovation #FunctionalMushroomsWant to see last week's recap?   • Top Cannabis Developments This Week: Tyson...  Want to see more Cannabis Reform videos?   • Rand Paul Warns GOP Hemp Ban Would Destroy...     • Texas GOP War Over Cannabis: Abbott vs. Pa...     • Big Beautiful Bill Passes—Is Cannabis Refo...     • Could Cannabis Reform Win Trump the Youth ...  Want to be updated on Cannabis, Small Cap, AI, and Crypto? Subscribe to our Daily Baked in Newsletter!https://newsletter.thedalesreport.com...Find us as well on Facebook, Twitter, Instagram, LinkedIn and on the Web:Facebook:   / thedalesreport  Twitter:

Listen Now